TCR repertoire intratumor heterogeneity in localized lung adenocarcinomas: an association with predicted neoantigen heterogeneity and postsurgical recurrence

A Reuben, R Gittelman, J Gao, J Zhang, EC Yusko… - Cancer discovery, 2017 - AACR
A Reuben, R Gittelman, J Gao, J Zhang, EC Yusko, CJ Wu, R Emerson, J Zhang, C Tipton…
Cancer discovery, 2017AACR
Genomic intratumor heterogeneity (ITH) may be associated with postsurgical relapse of
localized lung adenocarcinomas. Recently, mutations, through generation of neoantigens,
were shown to alter tumor immunogenicity through T-cell responses. Here, we performed
sequencing of the T-cell receptor (TCR) in 45 tumor regions from 11 localized lung
adenocarcinomas and observed substantial intratumor differences in T-cell density and
clonality with the majority of T-cell clones restricted to individual tumor regions. TCR ITH …
Abstract
Genomic intratumor heterogeneity (ITH) may be associated with postsurgical relapse of localized lung adenocarcinomas. Recently, mutations, through generation of neoantigens, were shown to alter tumor immunogenicity through T-cell responses. Here, we performed sequencing of the T-cell receptor (TCR) in 45 tumor regions from 11 localized lung adenocarcinomas and observed substantial intratumor differences in T-cell density and clonality with the majority of T-cell clones restricted to individual tumor regions. TCR ITH positively correlated with predicted neoantigen ITH, suggesting that spatial differences in the T-cell repertoire may be driven by distinct neoantigens in different tumor regions. Finally, a higher degree of TCR ITH was associated with an increased risk of postsurgical relapse and shorter disease-free survival, suggesting a potential clinical significance of T-cell repertoire heterogeneity.
Significance: The present study provides insights into the ITH of the T-cell repertoire in localized lung adenocarcinomas and its potential biological and clinical impact. The results suggest that T-cell repertoire ITH may be tightly associated to genomic ITH and disease relapse. Cancer Discov; 7(10); 1088–97. ©2017 AACR.
This article is highlighted in the In This Issue feature, p. 1047
AACR